These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 10909011

  • 1. Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass (S53P4).
    Peltola M, Suonpää J, Aitasalo K, Määttänen H, Andersson O, Yli-Urpo A, Laippala P.
    Acta Otolaryngol Suppl; 2000; 543():167-9. PubMed ID: 10909011
    [Abstract] [Full Text] [Related]

  • 2. Clinical follow-up method for frontal sinus obliteration with bioactive glass S53P4.
    Peltola MJ, Suonpää JT, Määttänen HS, Varpula MJ, Aitasalo KM, Yli-Urpo A, Laippala PJ.
    J Biomed Mater Res; 2001; 58(1):54-60. PubMed ID: 11152998
    [Abstract] [Full Text] [Related]

  • 3. In vitro model for frontal sinus obliteration with bioactive glass S53P4.
    Peltola MJ, Suonpää JT, Andersson H, Määttänen HS, Aitasalo KM, Yli-Urpo A, Laippala PJ.
    J Biomed Mater Res; 2000; 53(2):161-6. PubMed ID: 10713562
    [Abstract] [Full Text] [Related]

  • 4. Obliteration of the frontal sinus cavity with bioactive glass.
    Peltola M, Suonpää J, Aitasalo K, Varpula M, Yli-Urpo A, Happonen RP.
    Head Neck; 1998 Jul; 20(4):315-9. PubMed ID: 9588704
    [Abstract] [Full Text] [Related]

  • 5. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience.
    Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A.
    Head Neck; 2006 Sep; 28(9):834-41. PubMed ID: 16823870
    [Abstract] [Full Text] [Related]

  • 6. In vivo model for frontal sinus and calvarial bone defect obliteration with bioactive glass S53P4 and hydroxyapatite.
    Peltola MJ, Aitasalo KM, Suonpää JT, Yli-Urpo A, Laippala PJ.
    J Biomed Mater Res; 2001 May 01; 58(3):261-9. PubMed ID: 11319739
    [Abstract] [Full Text] [Related]

  • 7. Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.
    Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho AJ.
    J Biomed Mater Res B Appl Biomater; 2009 Jul 01; 90(1):131-6. PubMed ID: 18988277
    [Abstract] [Full Text] [Related]

  • 8. Histological comparison of healing extraction sockets implanted with bioactive glass or demineralized freeze-dried bone allograft: a pilot study.
    Froum S, Cho SC, Rosenberg E, Rohrer M, Tarnow D.
    J Periodontol; 2002 Jan 01; 73(1):94-102. PubMed ID: 11846205
    [Abstract] [Full Text] [Related]

  • 9. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
    Vos J, de Vey Mestdagh P, Colnot D, Borggreven P, Orelio C, Quak J.
    Eur Arch Otorhinolaryngol; 2017 Dec 01; 274(12):4121-4126. PubMed ID: 28956143
    [Abstract] [Full Text] [Related]

  • 10. Long-term microscopic and tissue analytical findings for 2 frontal sinus obliteration materials.
    Peltola MJ, Aitasalo KM, Aho AJ, Tirri T, Suonpää JT.
    J Oral Maxillofac Surg; 2008 Aug 01; 66(8):1699-707. PubMed ID: 18634960
    [No Abstract] [Full Text] [Related]

  • 11. A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.
    Lindfors NC, Koski I, Heikkilä JT, Mattila K, Aho AJ.
    J Biomed Mater Res B Appl Biomater; 2010 Jul 01; 94(1):157-64. PubMed ID: 20524190
    [Abstract] [Full Text] [Related]

  • 12. Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study.
    Peltola MJ, Aitasalo KM, Suonpää JT, Yli-Urpo A, Laippala PJ, Forsback AP.
    J Biomed Mater Res B Appl Biomater; 2003 Jul 15; 66(1):364-72. PubMed ID: 12808596
    [Abstract] [Full Text] [Related]

  • 13. [Obliterating frontal sinus operation with abdominal fat. Follow-up with imaging methods].
    Bottermann B, Berghaus A.
    HNO; 1998 Nov 15; 46(11):919-24. PubMed ID: 9864676
    [Abstract] [Full Text] [Related]

  • 14. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.
    Sarin J, Grénman R, Aitasalo K, Pulkkinen J.
    Ann Otol Rhinol Laryngol; 2012 Sep 15; 121(9):563-9. PubMed ID: 23012893
    [Abstract] [Full Text] [Related]

  • 15. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC, Villain B, Glombitza M, Blokhuis T, Heinänen M, Bégué T.
    Injury; 2022 Oct 15; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [Abstract] [Full Text] [Related]

  • 16. Report on results of frontal sinus obliterations in Turku University Central Hospital 1977-1994.
    Wide K, Sipilä J, Suonpää J.
    Acta Otolaryngol Suppl; 1997 Oct 15; 529():184-6. PubMed ID: 9288305
    [Abstract] [Full Text] [Related]

  • 17. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA, Glombitza M, Dahmen J, Hax PM, Steinhausen E.
    Z Orthop Unfall; 2018 Apr 15; 156(2):152-159. PubMed ID: 29665602
    [Abstract] [Full Text] [Related]

  • 18. An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.
    Sohrabi K, Saraiya V, Laage TA, Harris M, Blieden M, Karimbux N.
    J Periodontol; 2012 Apr 15; 83(4):453-64. PubMed ID: 21861641
    [Abstract] [Full Text] [Related]

  • 19. Operative treatment of frontal sinusitis.
    Suonpää J, Sipilä J, Aitasalo K, Antila J, Wide K.
    Acta Otolaryngol Suppl; 1997 Apr 15; 529():181-3. PubMed ID: 9288304
    [Abstract] [Full Text] [Related]

  • 20. The Viability and Growth of HaCaT Cells After Exposure to Bioactive Glass S53P4-Containing Cell Culture Media.
    Sarin J, Vuorenmaa M, Vallittu PK, Grénman R, Boström P, Riihilä P, Nissinen L, Kähäri VM, Pulkkinen J.
    Otol Neurotol; 2021 Jun 01; 42(5):e559-e567. PubMed ID: 33577242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.